Quarterly dematerialisation compliance certificate filed with exchanges

Compliance View source PDF Explain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹417.55

prior close

₹417.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+2.9% vs market

Pharmaceuticals peers, median of 172sector-2.5%+2.6% vs sector

On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 2.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-1.3

15m

-0.6

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1-2.8+2.9-2.5+2.6

Next day

-1.2-2.5+1.3-2.6+1.4

-1.4-1.7+0.3-2.5+1.1

-1.9-1.5-0.4-2.6+0.7

-4.1-0.8-3.3-2.5-1.6

-5.2-2.4-2.7-3.2-2.0

-4.4-3.4-1.1-4.3-0.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarti Drugs submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate was issued by the company's Registrar and Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime). It confirms that securities received for dematerialisation during the quarter were accepted or rejected, and the underlying shares have been listed on BSE and NSE. Cancelled physical certificates were mutilated and the depository's name was substituted as registered owner within prescribed timelines.

Likely market impact

Routine procedural compliance filing with no material impact on business or stock price.